HPB Malignancy Clinical Trials Have Low Enrollment, Disparities

Clinical trial participation is low among people with hepatopancreatobiliary malignancy. Data from the National Cancer Database for 511,639 patients showed 0.3% of patients were enrolled in clinical trials; Black and Hispanic patients were less likely to be enrolled than White patients.

Via HPB. Published online January 5, 2022.